
Merck COVID-19 pill: FDA panel weighs safety, effectiveness
Fox News
Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill for patients to take at home to treat COVID-19.
The meeting comes as U.S. infections are rising again and health authorities worldwide size up the threat posed by the new omicron variant.
If authorized, Merck’s pill would be the first that doctors could prescribe for patients to take on their own to ease symptoms and speed recovery, a major step toward reducing hospital caseloads and deaths. The drug, molnupiravir, is already authorized for emergency use in the U.K.
More Related News